Influence of intercurrent respiratory tract infections on inhaled human insulin (Exubera®) therapy: a retrospective pooled analysis of controlled phase 2/3 trials

P. Camus, R. J. Riese, J. G. Teeter (Dijon, France; Groton, United States Of America)

Source: Annual Congress 2006 - Primary care management of respiratory disease
Session: Primary care management of respiratory disease
Session type: Electronic Poster Session
Number: 4230
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Camus, R. J. Riese, J. G. Teeter (Dijon, France; Groton, United States Of America). Influence of intercurrent respiratory tract infections on inhaled human insulin (Exubera®) therapy: a retrospective pooled analysis of controlled phase 2/3 trials. Eur Respir J 2006; 28: Suppl. 50, 4230

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Evaluation of ICS/LABA combination therapy on respiratory function in patients with asthma: Open-label, randomized, cross-over trial.
Source: International Congress 2018 – New developments in the treatment of asthma
Year: 2018


Phase III trial of tiotropium as add-on therapy to low-dose inhaled corticosteroids for patients with symptomatic mild persistent asthma: Design and planned analyses
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013


Reducing the frequency of respiratory tract infections in severe neurological disorders by inhaled antibiotics: a retrospective data analysis
Source: ERJ Open Res, 5 (3) 00149-2018; 10.1183/23120541.00149-2018
Year: 2019



Safety and benefit of adjunctive systemic corticosteroid therapy in the management of severe, smear positive pulmonary tuberculosis (SSP-PTB); an interim analysis of a randomized controlled trial
Source: Annual Congress 2012 - Tuberculosis: clinical findings II
Year: 2012


High-dose inhaled corticosteroids prevent wheeze following respiratory syncytial virus infection: a randomized double-blind placebo-controlled trial
Source: Annual Congress 2008 - Paediatric respiratory epidemiology II: air pollution studies and infectious disease epidemiology
Year: 2008

Mechanistic model based meta-analysis for paediatric respiratory tract infection prophylaxis trial design
Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function
Year: 2021


How to reduce COPD exacerbations with inhaled drugs? A pooled analysis of randomized trials
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008

Effect of high dose inhaled beclomethasone for respiratory syncytial virus bronchiolitis during infancy on lung function and asthma at age 6 – A randomised placebo-controlled trial
Source: Annual Congress 2013 –The best of paediatric asthma and allergy
Year: 2013


Placebo-controlled, double-blind trial of chronic, intermittent ‘pulse‘ therapy of moxifloxacin to prevent acute exacerbations in COPD patients with chronic bronchitis: baseline data
Source: Annual Congress 2006 - Clinical aspects and treatment of lower respiratory infection in COPD patients
Year: 2006


Effect of high or low-medium accumulated dose regimes of systemic corticosteroids for hospitalised patients with exacerbated chronic obstructive pulmonary disease: pooled analysis of individual participant data from the REDUCE and CORTICO-COP trials
Source: Virtual Congress 2021 – COPD pharmacology: from basic science to real-world data
Year: 2021



Effects of a home programme of airway clearance techniques on adventitious respiratory sounds in patients with bronchiectasis: a randomised controlled trial
Source: International Congress 2018 – The global impact of bronchiectasis and nontuberculous mycobacteria (NTM)
Year: 2018


A multicenter randomised controlled trial to evaluate continuous-positive airway pressure (CPAP) versus conventional oxygen in patients with acute respiratory failure (ARF) due to community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Riding the tiger: noninvasive ventilation and acute respiratory failure
Year: 2009

Feasibility of shortening intravenous antibiotic therapy for bronchiectasis based on bacterial load: a proof-of-concept randomised controlled trial
Source: Eur Respir J, 58 (6) 2004388; 10.1183/13993003.04388-2020
Year: 2021



The effect of low-dose corticosteroids and theophylline on the risk of acute exacerbations of COPD: the TASCS randomised controlled trial
Source: Eur Respir J, 57 (6) 2003338; 10.1183/13993003.03338-2020
Year: 2021



Long-acting bronchodilators (LABDs) and major adverse cardiac events (MACE) in patients with COPD: A pooled analysis of 12 randomised trials
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016

Comparative effectiveness of two different doses of inhaled corticosteroid in triple therapy on exacerbations in patients with severe COPD: a real-world study
Source: Virtual Congress 2021 – Therapies for respiratory diseases in primary care and COVID - 19
Year: 2021


Humidified and standard oxygen therapy in acute severe asthma in children: a randomised controlled pilot trial (HUMOX)
Source: International Congress 2018 – Paediatric asthma: prevention, diagnosis and treatment
Year: 2018




Open-label, randomized, comparative trial of the efficacy of levofloxacin versus clarithromycin SR therapy in complicated infectious exacerbation of COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 674s
Year: 2007

The results of a randomized clinical trial of the efficacy of the antibodies-based drug in influenza and acute respiratory viral infections in children
Source: International Congress 2019 – New insights into childhood infections: from viral bronchiolitis to bronchiolitis obliterans
Year: 2019


Efficacy of mometasone/indacaterol/glycopyrronium (MF/IND/GLY) on lung function and exacerbations in patients with inadequately controlled asthma with high-dose ICS/LABA therapy (on GINA step 5) prior to study entry: Results from IRIDIUM study
Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence
Year: 2021